First human trial tests new Drug's safety
NCT ID NCT06277492
Summary
This was an early-stage study to check the safety and see how the body processes a new drug called SUL-238. It involved 83 healthy volunteers aged 40 and older. Researchers tested different single and repeated doses to find the highest safe amount and measured how the drug moves through the body.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY SUBJECTS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Erciyes University IKUM Center
Kayseri, 38030, Turkey (Türkiye)
Conditions
Explore the condition pages connected to this study.